Provided by Tiger Fintech (Singapore) Pte. Ltd.

Shattuck Labs, Inc.

0.9396
+0.06727.70%
Pre-market: 0.98650.0469+4.99%08:00 EDT
Volume:79.20K
Turnover:73.12K
Market Cap:45.01M
PE:-0.68
High:0.9624
Open:0.9190
Low:0.8501
Close:0.8724
Loading ...

Company Profile

Company Name:
Shattuck Labs, Inc.
Exchange:
NASDAQ
Establishment Date:
2016
Employees:
44
Office Location:
500 West 5th Street,Suite 1200,Austin,Texas,United States
Zip Code:
78701
Fax:
- -
Introduction:
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Directors

Name
Position
Josiah Hornblower
Executive Chairman and Director
Taylor Schreiber
Chief Executive Officer and Director
George Golumbeski
Director
Helen M. Boudreau
Director
Michael Lee
Director
Neil Gibson
Director
Tyler Brous
Director

Shareholders

Name
Position
Taylor Schreiber
Chief Executive Officer and Director
Andrew R. Neill
Vice President of Finance and Corporate Strategy
Casi DeYoung
Chief Business Officer
Erin Ator Thomson
General Counsel
Josiah Hornblower
Executive Chairman and Director
Lini Pandite
Chief Medical Officer